AMR is threatening human and animal health as well as the environment. The consequences of inaction are too grave to contemplate.
The EU ban on the routine use of antimicrobials in animal production starts applying in January 2022. EPHA joins in asking the Commission about what preparations are being taken to ensure compliance with these rules?
The Pharmaceutical Strategy is a chance to tackle antimicrobial resistance that Europe cannot miss says the MEP Interest Group on AMR
Members of the European Parliament from the MEP Interest Group on AMR and supporting MEPs call on the European Commission to ensure the proposed Pharmaceutical Strategy includes strong measures to tackle antimicrobial resistance
About the AMR Stakeholder Network
About the MEP Interest Group on AMR
Analysis & Opinion
A report on the third online discussions organised by the MEP Interest Group on AMR the development of new needs-driven models to finance and stimulate antibiotic R&D could be supported and how the EU could promote R&D models that ensure responsible use of and equitable and affordable access to antibiotics.
A report on the second of the online discussions organised by the MEP Interest Group on AMR on what measures can be taken to reduce the use of antimicrobials in agriculture
Selected resources produced by the Joint Action on Antimicrobial Resistance and Healthcare-related Infections (EU-JAMRAI)
EPHA #A2MDialogues: Sustainable access to effective antibiotics - what should the EU do?
15 April 2021
MEP Interest Group on AMR: 2020 Webinar Series
13,16, 17 November
AMR: setting the agenda for change Official launch of the MEP Interest Group on AMR
19 February 2019
Invest and Protect
7 May 2019
Joining the Dots
30 January 2018
Subscribe to the EPHA AMR Feed!
Do you have a question?
Meet our AMR Policy Leads and Scientific Advisors
Rose Gallagher MBE
EPHA Scientific Advisor on AMR
Professional Lead Infection Prevention & Control, Royal College of Nursing (UK)